CClinicalTrials.gg
RecruitingNCT06057415NeoHemoHaptUpdated Aug 27, 2024

Improving Gastrointestinal Function In High-Risk Newborns By Stimulation Of The Enteric Nervous System

An interventional study of HAPTOS (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation in Feeding and Eating Disorders, sponsored by Radboud University Medical Center. Recruiting at 1 site in Netherlands. Open to participants aged Up to 2 Days. Per ClinicalTrials.gov, last updated 2024-08-27.

Sponsored by Radboud University Medical Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jun 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
Up to 2 Days
Sex
All
01

Study summary

The goal of this therapeutical intervention trial is to investigate whether tactile-kinesthaetic and oral sensorimotor stimulation can improve gastrointestional function in preterm infants born before gestational age of 30 weeks and newborns with congenital diaphragmatic hernia. The main question it aims to answer is:

  • To determine whether HAPTOS- intervention (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation) in the particpants results in earlier attainment (postnatal days) of full enteral feeding and/or full oral feeding (post menstrual age) compared to standard care. Researchers will compare an intervention group receiving standard of care plus HAPTOS intervention to a group of patients receiving only current standard of care.
Read the detailed description

Infants born preterm or with congenital diaphragmatic hernia (CDH) are at risk for several long-term unfavourable outcomes that can be related to feeding difficulties from birth onwards. Adverse nutritional outcomes in both patient groups mainly originate from mechanical dysfunction, based on dysmotility. Mechanical function includes suck-swallow coordination, gastrointestinal sphincter tone, gastric emptying and intestinal motility and is regulated by the complex interplay of the autonomic (ANS) and enteric (ENS) nervous system with modulation by the central nervous system (CNS). The intra-uterine environment provides the fetus with developmentally timed sensory exposures through 'touch' that are necessary for development of sensory control and autonomous coordination of bodily functions. Preterm infants miss out this normal maturation, while newborns with CDH may exhibit a delayed maturation probably as a result of the deviant anatomical situation and the severe illness during the direct postnatal period. In the postnatal situation both patient groups may be confronted with either 'negative' sensory stimulation through exposures such as procedural touch/handling, pain or otherwise a reduction in sensory exposures through avoidance of positive touch in relation to supposed clinical instability. All together this may affect normal development and may lead to sensory deprivation and delayed maturation of the nervous regulation and cerebral maturation. Tactile-kinaesthetic and oral sensorimotor stimulation using positive gentle touch have been shown to positively affect cardiorespiratory stability, weight gain, gastro-intestinal performance, and length of stay in hospital for preterm infants. However, these strategies have not been evaluated in high-risk infants. The current study aims at evaluating an intervention programme that provides positive stimuli through touch adapted to the stage of development of the infant with regard to timing, duration and intensity that supports the maturational development of gastrointestinal functionality. (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation; HAPTOS intervention). We hypothesize that the HAPTOS intervention will improve the postnatal maturation of the autonomous and enteral nervous system and cause improvements in gastrointestinal motility, enteral and oral feeding and cardiorespiratory stability.

02

Conditions studied

  • Feeding and Eating Disorders

Keywords

  • preterm infants
  • high-risk newborns
  • congenital diaphragmatic hernia
  • autonomous nervous system
  • tactile stimulation
03

In context

Feeding and Eating Disorders

740 studies on the registry are indexed under Feeding and Eating Disorders; 159 are open to participants now.

This study's planned enrollment of 200 is above the median of 75 across 540 interventional studies indexed under Feeding and Eating Disorders.

Browse Feeding and Eating Disorders studies →

Lead sponsor

Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 2 Days
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Preterm birth at gestational age \< 30 weeks or
  2. Diagnosis of Congenital Diaphragmatic Hernia
  3. Born at Amalia Children's Hospital or admitted 1rst day of life
  4. Written informed consent of both parents or representatives

Exclusion criteria

Exclusion Criteria:

  1. Preterm infant born at gestational age ≥ 30 weeks
  2. Perinatal Asphyxia; (Apgar score at 5' \< 5 and first pH ≤ 7,0)
  3. Major congenital anomalies or birth defects other than congenital diaphragmatic hernia;
  4. Metabolic disease that necessitates a special diet other than human milk or formula feeding and or has a prognosis of impaired neurological development
  5. Parental refusal of participation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • No intervention
    Standard care

    Will receive standard of care according to the institutional protocol and principles of developmental care which currently belongs to (inter-) national guidelines and is regarded as safe.

  • Experimental
    Standard care supplemented with HAPTOS intervention

    Will receive standard of care according to the principles of developmental care which currently belongs to (inter-) national guidelines plus HAPTOS intervention which includes: tactile/ kinaesthetic massage of the trunk and extremities twice daily and stimulation of oral function by providing perioral stimulation up to 4 times a day. Interventions will be continued until clinical improvement.

    Procedure: HAPTOS (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation

Interventions

  • ProcedureHAPTOS (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation

    Tactile-kinaesthetic and Oral sensorimotor Stimulation

06

What researchers measure

Primary outcomes

  1. Number of days to achieve full enteral feeding

    measuring the time from birth until enteral intake reaches 150ml/kg/d

    Time frame: 60 days

  2. Postmenstrual age at achievement of full oral feeding

    Number of postmenstrual weeks until gastrointestinal tube is taken out

    Time frame: 52 weeks

Secondary outcomes

  1. First meconium passage

    Postnatal day at first meconium

    Time frame: 14 days

  2. Duration of meconium passage

    Number of days until normal defecation

    Time frame: 14 days

  3. Use of laxatives

    Number of laxatives given

    Time frame: 60 days

  4. Gastrointestinal Motility

    Volume of gastric residuals per week

    Time frame: 100 days

  5. Vomiting

    Number of incidences of vomiting in combination with aspiration

    Time frame: duration of hospitalization up to 15 months

  6. Periodic breathing

    Number of desaturations \< 80% and/or bradycardia \< 80/min that require intervention per week

    Time frame: duration of hospitalization up to 15 months

  7. Feeding difficulties

    Number of infants with impaired oral motor skills

    Time frame: 24 months

  8. Maturation of heart rate variability

    Number of infants with delayed regulation of the para- and sympathicus tonus measured continuously through monitordata collection

    Time frame: duration of intensive care stay up to 60 days

  9. Growth at postmenstrual age

    Gain in weight, length, and head circumference including percentiles

    Time frame: at 40 weeks, 3, 6, 12, 18 and 24 weeks

  10. Morbidity

    Number of infants with necrotizing enterocolitis, spsis, chronic lung disease, retinopathy of prematurity, intra-ventricular hemorrhage

    Time frame: 100 days

  11. Duration hospital stay

    Postnatal age at time of discharge home

    Time frame: 100 days

  12. Neurocognitive development

    Measuring cognitive and motor development using Bayley Scores of Infant Development (BSID III)

    Time frame: at 24 months

  13. Parent participation in care

    Measuring number of parents who participate and frequency of activity

    Time frame: duration of hospitalization up to 100 days

07

Study locations

1 of 1 sites recruiting
  • Radboud University Nijmegen Medical Centre
    Nijmegen, 6500 HB, Netherlands
    • V Christmann, dr. · Contact · v.christmann@radboudumc.nl · 0031243613936
    • M Nelissen, MSc · Contact · m.nelissen@radboudumc.nl · 0031630368351
    • M Nelissen, MSc · Sub investigator
    • W P de Boode, prof.dr. · Principal investigator
    • V Christmann, dr. · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06057415
Lead sponsor
Radboud University Medical Center
Collaborators
Nutricia Research
Responsible party
Sponsor
First posted
Sep 28, 2023
Start date
Jun 10, 2024
Primary completion
May 31, 2026 (estimated)
Completion
May 31, 2028 (estimated)
Last update
Aug 27, 2024

Study contacts

Yvet Kroeze
Contact
pediatricresearchunit@radboudumc.nl
+31 (0)24 36 55 700
Viola Christmann, MD,PhD
Contact
viola.christmann@radboudumc.nl
Viola Christmann, MD, PhD
principal investigator · Radboud University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion